The majority of previous publications showed that Her2-postive status provided additional prognostic information and was associated with relevant clinicopathologic characteristics, such as serosal invasion and lymph node metastasis [31–33]. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.